With regard to South Korea, Novartis settled specified effectively-publicized allegations that it experienced made incorrect payments to HCPs in South Korea through spherical tables and third-party clinical journals. Novartis Korea allegedly transmitted incorrect honoraria to HCPs for spherical tables by way of health-related journals to stay away